Circular RNAs: Novel Players in the Oxidative Stress-Mediated Pathologies, Biomarkers, and Therapeutic Targets

被引:13
|
作者
Wang, Yunguang [1 ]
He, Wenfang [2 ]
Ibrahim, Sherif A. [3 ]
He, Qiang [2 ]
Jin, Juan [4 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hangzhou Peoples Hosp 1, Dept Crit Care Med, Hangzhou 310006, Zhejiang, Peoples R China
[2] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Nephrol, Hangzhou 310014, Zhejiang, Peoples R China
[3] Mansoura Univ, Fac Med, Dept Histol & Cell Biol, Mansoura, Egypt
[4] Hangzhou Med Coll, Affiliated Linan Peoples Hosp, Peoples Hosp Hangzhou Linan Dist 1, Dept Nephrol, Hangzhou 311300, Zhejiang, Peoples R China
关键词
ALPHA-SYNUCLEIN EXPRESSION; INJURY; PATHOPHYSIOLOGY; TRANSCRIPTION; ANTIOXIDANT; MICRORNA; ABUNDANT; REVEALS; DISEASE; GENE;
D O I
10.1155/2021/6634601
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Oxidative stress (OxS) is a wildly described cause of damage to macromolecules, resulting in abnormal physiological conditions. In recent years, a few studies have shown that oxidation/antioxidation imbalance plays a significant role in developing diseases involving different systems and organs. However, the research on the circular RNA (circRNA) roles in OxS is still in its very infancy. Therefore, we hope to provide a comprehensive overview of the recent research that explored the function of circRNAs associated with OxS and its role in the pathogenesis of different diseases that affect different body systems like the nervous system, cardiovascular system, kidneys, and lungs. It provides the possibilities of using these circRNAs as superior diagnostic and therapeutic options for OxS associated with these disease conditions.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Circular RNAs Serve as Novel Biomarkers and Therapeutic Targets in Cancers
    Fang, Shuai
    Pan, Jinchang
    Zhou, Chengwei
    Tian, Hui
    He, Jinxian
    Shen, Weiyu
    Jin, Xiaofeng
    Meng, Xiaodan
    Jiang, Nan
    Gong, Zhaohui
    CURRENT GENE THERAPY, 2019, 19 (02) : 125 - 133
  • [2] Circular RNAs as biomarkers and therapeutic targets in cancer
    Beilerli, Aferin
    Gareev, Ilgiz
    Beylerli, Ozal
    Yang, Guang
    Pavlov, Valentin
    Aliev, Gjumrakch
    Ahmad, Aamir
    SEMINARS IN CANCER BIOLOGY, 2022, 83 : 242 - 252
  • [3] Circular RNAs as Novel Diagnostic Biomarkers and Therapeutic Targets in Kidney Disease
    Yu, Jianwen
    Xie, Danli
    Huang, Naya
    Zhou, Qin
    FRONTIERS IN MEDICINE, 2021, 8
  • [4] Circulating circular RNAs: Novel potential biomarkers and therapeutic targets for oral cancer
    Paramasivam, Arumugam
    ORAL ONCOLOGY, 2022, 134
  • [5] Circular RNAs as biomarkers and therapeutic targets for gastrointestinal cancers
    Botwe, Godwin
    Fang, Xinjian
    Mukhtar, Yusif Mohammed
    Zhou, Yue
    Tang, Haozhou
    Wang, Maoye
    Zhang, Jiahui
    Fu, Min
    Jiang, Pengcheng
    Gu, Jianmei
    Zhang, Xu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (07) : 1230 - 1246
  • [6] Insights about exosomal circular RNAs as novel biomarkers and therapeutic targets for hepatocellular carcinoma
    Zhang, Haiyan
    Pei, Shanshan
    Li, Jiaxuan
    Zhu, Jiajie
    Li, Hongyu
    Wu, Guangshang
    Weng, Ruiqi
    Chen, Ruyi
    Fang, Zhongbiao
    Sun, Jingbo
    Chen, Keda
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] Circular RNAs in Gastric Cancer: Potential Biomarkers and Therapeutic Targets
    Ouyang, Jiafeng
    Long, Zhi
    Li, Guoqing
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [8] Circular RNAs: Potential biomarkers and therapeutic targets for autoimmune diseases
    Zhao, Ren-Jie
    Zhang, Wan-Ying
    Fan, Xing-Xing
    HELIYON, 2024, 10 (01)
  • [9] Circular RNAs as Potential Biomarkers and Therapeutic Targets for Metabolic Diseases
    Zaiou, Mohamed
    REVIEWS ON BIOMARKER STUDIES OF METABOLIC AND METABOLISM-RELATED DISORDERS, 2019, 1134 : 177 - 191
  • [10] Circular RNAs: Novel Players in Cancer Mechanisms and Therapeutic Strategies
    Kim, Jimi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)